Dawn Sherman

President & CEO

Dawn brings a wealth of strategic leadership experience to ProPharma Group. She has worked extensively within the healthcare industry, holding roles such as President, COO, and Global Managing Director for several global healthcare companies.

Prior to becoming President of ProPharma Group, Dawn was President of EnvisionRx, a national, full-service pharmacy benefit management company. Dawn was responsible for EnvisionRx, MedTrakRx, EnvisionPharmacies, Envision Savings, and LakerSoftware, as well as several functional areas such as strategy, product development, pricing, client analytics, IT, manufacturer and provider relations, marketing, and customer service operations. Dawn also led all integration efforts with Rite Aid since the acquisition of EnvisionRx by Rite Aid in June 2015.

Prior to joining EnvisionRx, Dawn served as Chief Operating Officer (COO) for Teva Pharmaceuticals Europe B.V., where she had oversight of commercial operations across 36 countries as well as global responsibility for patient solutions. Dawn’s broad focus included strategy and innovation for patient support, commercial effectiveness, market access, business insights and intelligence, and government affairs. Additionally, Dawn had responsibility for corporate communications and driving organizational efficiency and effectiveness.

Before joining Teva, Dawn was Chief Operating Officer of Medco International, B.V., where she focused on delivering innovative, integrated clinical services to improve efficiency across the European healthcare system. Before relocating to the Netherlands, Dawn held other roles during her tenure with Medco Health Solutions, Inc., such as Senior Vice President and Chief Operating Officer for Medco’s international strategy and operations, where she led activities related to integrating and operationalizing international business opportunities within Medco.

Prior to Medco, Dawn was Global Managing Director for Hay Group Insight, Hay Group’s survey research division. In this role, she worked with executive management teams and board members from Fortune 100 companies in a wide spectrum of industries with a focus on improving organizational and operational effectiveness.

Dawn completed her undergraduate work at Miami University with degrees in Psychology and Sociology and received her master’s degree in Sociology from New York University.

Company Blog

November 29, 2018
Industry Poll: How Can Your GMP Auditing Program Be Most…
Expert insight into how you can take steps to best improve your GMP auditing… Read More
November 15, 2018
The Important Role of Advanced Therapy Medicinal Products
Today on the blog, a personal perspective from a colleague on the impact and… Read More
October 16, 2018
Outdated Facilities – Bring Back the ‘c’ in cGMP
Bringing the ‘c’ in the cGMP status back into your facility, processes, or procedures… Read More
More Articles

UPCOMING Events

January 28, 2019
DIA Pharmacovigilance and Risk Management Strategies Conference
Join us at DIA’s Pharmacovigilance and Risk Management Strategies Conference for context, background,... Read More
February 18, 2019
SCOPE – Summit for Clinical Ops Executives
SCOPE Summit 2019 takes place February 18-21 in Orlando, FL. Over the course of four stimulating days of in-de... Read More
March 18, 2019
DIA Medical Affairs and Scientific Communications
DIA’s Medical Affairs and Scientific Communications Forum is designed for medical affairs professionals, b... Read More
All Events
Contact Us